Tag: slides
-
KaloBios stock slides; to stop asthma study – MarketWatch
KaloBios stock slides; to stop asthma studyMarketWatchKaloBios Pharmaceuticals Inc.'s (NASDAQ:KBIO) shares slumped after the company said it would discontinue development of a treatment for severe asthma, a move that followed disappointing Phase 2 results. Chief Executive Officer David Pritchard said …KaloBios Reports Top-Line Data for Phase 2 Study of KB003 in Severe Asthma …Benzingaall 2 news…
-
Skyepharma slides as US group ends asthma drug deal – The Guardian
Stockopedia Skyepharma slides as US group ends asthma drug dealThe GuardianShares in Skyepharma have fallen around 5% after another setback for its asthma treatment flutiform. The company has announced that Abbott Laboratories has …SkyePharma loses US partnerGrowthBusiness.co.ukAbbot shelves interest in SkyePharma's FlutiformShareCastSkyePharma says Abbott ends US Flutiform dealReutersWall Street Journal –Stockopediaall 8 news articles » View full…